Learn More
Medchemexpress LLC L-Arginine, N2-(1-oxo-3-phenylpropyl)-L-ornithyl-L-prolyl-3-cyclohexyl-D-alanyl-L-tryptophyl-, (5→1)-lactam | 514814-49-4 | 99.5% | 839.04 | 50 MG

Supplier: Medchemexpress LLC HY11013610MG
PMX 205 is a potent and orally active complement C5a receptor (C5aR; CD88) antagonist. This selective antagonist is extensively used in research for its biological activities and therapeutic potential across various disease models.
- Potent and selective complement C5a receptor (C5aR; CD88) antagonist.
- Orally active for convenience in in vivo studies.
- Demonstrated extended survival and reduced motor decline in neurological disease models.
- Reduced astroglial proliferation in spinal cord.
- Decreased fibrillar plaque load and hyperphosphorylated tau in Alzheimer's disease models.
- Blocked C5a-induced cellular expression changes and proliferation.
- Exhibited suppression of GPX4 expression and inhibition of tumor growth in specific studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.